0001104659-21-152294.txt : 20211221 0001104659-21-152294.hdr.sgml : 20211221 20211221180342 ACCESSION NUMBER: 0001104659-21-152294 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211218 FILED AS OF DATE: 20211221 DATE AS OF CHANGE: 20211221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carroll David Francis CENTRAL INDEX KEY: 0001703623 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 211510484 MAIL ADDRESS: STREET 1: ONE UNIVERSITY SQUARE DRIVE, SUITE 280 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PENN PLAZA STREET 2: SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: 5 PENN PLAZA STREET 2: SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 tm2135829-7_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-12-18 0 0001410939 IVERIC bio, Inc. ISEE 0001703623 Carroll David Francis C/O IVERIC BIO, INC. 5 PENN PLAZA, SUITE 2372 NEW YORK NY 10001 0 1 0 0 SVP, CFO and Treasurer Common Stock 2021-12-18 4 M 0 14375 A 111740 D Common Stock 2021-12-20 4 S 0 6710 15.4435 D 105030 D Restricted Stock Units 2021-12-18 4 M 0 14375 0 D Common Stock 14375 43125 D Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units. Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 18, 2021. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker on December 20, 2021 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. On December 18, 2020, the Reporting Person was granted an award of 57,500 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan. /s/ Todd Anderman, as Attorney-in-Fact for David F. Carroll 2021-12-21